Log In
Print
BCIQ
Print
Print this Print this
 

Recombinant Human ErbB3 fragment injection (rhErbB3-f)

  Manage Alerts
Collapse Summary General Information
Company Zensun (Shanghai) Sci. & Tech. Co. Ltd.
DescriptionRecombinant human ErbB3 fragment (rhErbB3-f) vaccine
Molecular Target Epidermal growth factor receptor 3 (EGFR3) (HER3) (ErbB3)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationBreast cancer
Indication DetailsTreat breast cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today